bioMerieux (OTCMKTS:BMXMF – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $131.00, but opened at $120.85. bioMerieux shares last traded at $120.85, with a volume of 123 shares.
bioMerieux Stock Up 3.5%
The business has a fifty day moving average of $126.20 and a 200 day moving average of $133.70. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08.
bioMerieux Company Profile
bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.
Further Reading
- Five stocks we like better than bioMerieux
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Do not delete, read immediately
- A month before the crash
- Claim Your Share of $5.39 BILLION in AI Equity Checks
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for bioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.
